Dixon Hubard Feinour & Brown Inc. VA boosted its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.2% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 21,727 shares of the pharmacy operator’s stock after buying an additional 36 shares during the period. Dixon Hubard Feinour & Brown Inc. VA’s holdings in Walgreens Boots Alliance were worth $1,804,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Baltimore Washington Financial Advisors Inc. bought a new position in Walgreens Boots Alliance during the fourth quarter worth approximately $17,135,000. Hudock Capital Group LLC boosted its position in Walgreens Boots Alliance by 0.4% in the first quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock worth $108,000 after buying an additional 5 shares during the last quarter. Tarbox Group Inc. boosted its position in Walgreens Boots Alliance by 288.3% in the first quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock worth $113,000 after buying an additional 1,006 shares during the last quarter. Howe & Rusling Inc. boosted its position in Walgreens Boots Alliance by 209.2% in the first quarter. Howe & Rusling Inc. now owns 1,441 shares of the pharmacy operator’s stock worth $120,000 after buying an additional 975 shares during the last quarter. Finally, Webster Bank N. A. boosted its position in Walgreens Boots Alliance by 18.4% in the first quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock worth $125,000 after buying an additional 235 shares during the last quarter. 61.20% of the stock is currently owned by hedge funds and other institutional investors.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 78.78 on Friday. The stock’s 50 day moving average is $78.90 and its 200-day moving average is $82.48. The stock has a market capitalization of $84.30 billion, a price-to-earnings ratio of 19.89 and a beta of 1.26. Walgreens Boots Alliance, Inc. has a 12 month low of $75.18 and a 12 month high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The company had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. During the same period in the prior year, the firm posted $1.18 EPS. The business’s revenue was up 2.1% compared to the same quarter last year. On average, equities research analysts expect that Walgreens Boots Alliance, Inc. will post $5.01 earnings per share for the current year.
Walgreens Boots Alliance announced that its Board of Directors has authorized a stock repurchase plan on Wednesday, April 5th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s leadership believes its shares are undervalued.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th will be issued a dividend of $0.40 per share. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date is Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.03%. Walgreens Boots Alliance’s dividend payout ratio is currently 37.78%.
TRADEMARK VIOLATION NOTICE: This article was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://stocknewstimes.com/2017/07/28/dixon-hubard-feinour-brown-inc-va-purchases-36-shares-of-walgreens-boots-alliance-inc-nasdaqwba.html.
A number of research firms have commented on WBA. Credit Suisse Group reaffirmed a “buy” rating and issued a $97.00 target price on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. Barclays PLC set a $79.00 target price on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Saturday, April 1st. Leerink Swann set a $86.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Friday, July 7th. Citigroup Inc. reissued a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Finally, Jefferies Group LLC reissued a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Friday, March 31st. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and fourteen have given a buy rating to the company. The company has an average rating of “Buy” and an average price target of $90.69.
In other news, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44. Following the transaction, the director now owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 13.50% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
